Paper16620142
Advances in the treatment of testicular cancer.
Kopp HG and 7 others. Drugs, 2006. Cited by 43 papers, by iCite.
Cite this record
ConductScience Library. Advances in the treatment of testicular cancer. Papers, record 16620142. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/16620142
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antineoplastic Combined Chemotherapy Protocols | Major topic |
| Seminoma | Major topic |
| Testicular Neoplasms | Major topic |
| Brain Neoplasms | |
| Combined Modality Therapy | |
| Humans | |
| Liver Neoplasms | |
| Male | |
| Neoplasm Staging | |
| Orchiectomy | |
| Prognosis | |
| Salvage Therapy |
Source PubMed
References150
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 12610187 | Intensive induction chemotherapy with CBOP/BEP in patients with poor prognosis germ cell tumors. | J Clin Oncol | 2003 | https://conductscience.org/library/papers/12610187 | PubMed |
| 2 | 9315391 | The International Germ Cell Consensus Classification: a new prognostic factor-based staging classification for metastatic germ cell tumours. | Clin Oncol (R Coll Radiol) | 1997 | https://conductscience.org/library/papers/9315391 | PubMed |
| 3 | 12686815 | Complications of primary nerve sparing retroperitoneal lymph node dissection for clinical stage I nonseminomatous germ cell tumors of the testis: experience of the German Testicular Cancer Study Group. | J Urol | 2003 | https://conductscience.org/library/papers/12686815 | PubMed |
| 4 | 8874322 | High-dose chemotherapy as salvage treatment in germ cell tumors: a multivariate analysis of prognostic variables. | J Clin Oncol | 1996 | https://conductscience.org/library/papers/8874322 | PubMed |
| 5 | 9666776 | Surgery as salvage therapy in chemotherapy-resistant nonseminomatous germ cell tumours. | Br J Urol | 1998 | https://conductscience.org/library/papers/9666776 | PubMed |
| 6 | 9093705 | Residual mass following chemotherapy of seminoma. | Ann Oncol | 1997 | https://conductscience.org/library/papers/9093705 | PubMed |
| 7 | 9072586 | Surgery for a post-chemotherapy residual mass in seminoma. | J Urol | 1997 | https://conductscience.org/library/papers/9072586 | PubMed |
| 8 | 15738984 | Testicular germ-cell tumours in a broader perspective. | Nat Rev Cancer | 2005 | https://conductscience.org/library/papers/15738984 | PubMed |
| 9 | 12796024 | Multicenter study evaluating a dual policy of postorchiectomy surveillance and selective adjuvant single-agent carboplatin for patients with clinical stage I seminoma. | Ann Oncol | 2003 | https://conductscience.org/library/papers/12796024 | PubMed |
| 10 | 11956262 | Activity of oxaliplatin in patients with relapsed or cisplatin-refractory germ cell cancer: a study of the German Testicular Cancer Study Group. | J Clin Oncol | 2002 | https://conductscience.org/library/papers/11956262 | PubMed |
| 11 | 9081388 | Phase II study of paclitaxel in patients with relapsed or cisplatin-refractory testicular cancer. | Ann Oncol | 1996 | https://conductscience.org/library/papers/9081388 | PubMed |
| 12 | 11283931 | Improved long term survival of patients with metastatic nonseminomatous testicular germ cell carcinoma in relation to prognostic classification systems during the cisplatin era. | Cancer | 2001 | https://conductscience.org/library/papers/11283931 | PubMed |
| 13 | 2439660 | The treatment of advanced metastatic seminoma: experience in 55 cases. | J Clin Oncol | 1987 | https://conductscience.org/library/papers/2439660 | PubMed |
| 14 | 7666083 | Stage I testicular seminoma: results of adjuvant irradiation and surveillance. | J Clin Oncol | 1995 | https://conductscience.org/library/papers/7666083 | PubMed |
| 15 | 2297486 | Long-term somatic side-effects and morbidity in testicular cancer patients. | Br J Cancer | 1990 | https://conductscience.org/library/papers/2297486 | PubMed |
| 16 | 10080592 | Phase II trial of gemcitabine in refractory germ cell tumors. | J Clin Oncol | 1999 | https://conductscience.org/library/papers/10080592 | PubMed |
| 17 | 8605273 | Hematopoietic growth factors and treatment of testicular cancer: biological interactions, routine use and dose-intensive chemotherapy. | Ann Hematol | 1996 | https://conductscience.org/library/papers/8605273 | PubMed |
| 18 | 2419524 | Prognostic factors for favorable outcome in disseminated germ cell tumors. | J Clin Oncol | 1986 | https://conductscience.org/library/papers/2419524 | PubMed |
| 19 | 10764433 | Cardiovascular morbidity in long-term survivors of metastatic testicular cancer. | J Clin Oncol | 2000 | https://conductscience.org/library/papers/10764433 | PubMed |
| 20 | 12697875 | Cardiovascular disease as a long-term complication of treatment for testicular cancer. | J Clin Oncol | 2003 | https://conductscience.org/library/papers/12697875 | PubMed |
Cited by20
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 43 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41844740 | CHD1L promotes testicular cancer progression through epigenetic activation of the CXCR6/PI3K/AKT pathway. | Sci Rep | 2026 | https://conductscience.org/library/papers/41844740 | PubMed |
| 41782041 | Severe multiorgan toxicities after the first cycle of standard-dose etoposide-cisplatin therapy for metastatic nonseminoma successfully managed with etoposide-carboplatin: a case report. | J Med Case Rep | 2026 | https://conductscience.org/library/papers/41782041 | PubMed |
| 40943467 | Medical Ozone Treatment Attenuates Male Reproductive Toxicity Induced by Bleomycin, Etoposide, and Cisplatin Regimen in an Experimental Animal Model. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/40943467 | PubMed |
| 38261810 | The ERF transcription factor LTF1 activates DIR1 to control stereoselective synthesis of antiviral lignans and stress defense in Isatis indigotica roots. | Acta Pharm Sin B | 2024 | https://conductscience.org/library/papers/38261810 | PubMed |
| 35488095 | Tissue-resident immunity in the female and male reproductive tract. | Semin Immunopathol | 2022 | https://conductscience.org/library/papers/35488095 | PubMed |
| 32857912 | METTL3 potentiates resistance to cisplatin through m6 A modification of TFAP2C in seminoma. | J Cell Mol Med | 2020 | https://conductscience.org/library/papers/32857912 | PubMed |
| 31906898 | Increased levels of XPA might be the basis of cisplatin resistance in germ cell tumours. | BMC Cancer | 2020 | https://conductscience.org/library/papers/31906898 | PubMed |
| 30870501 | Clonal analyses of refractory testicular germ cell tumors. | PLoS One | 2019 | https://conductscience.org/library/papers/30870501 | PubMed |
| 30123998 | Effect of Zinc on Spermatogenesis and Sperm Chromatin Condensation in Bleomycin, Etoposide, Cisplatin Treated Rats. | Cell J | 2019 | https://conductscience.org/library/papers/30123998 | PubMed |
| 29789926 | Patterns of platinum drug use in an acute care setting: a retrospective study. | J Cancer Res Clin Oncol | 2018 | https://conductscience.org/library/papers/29789926 | PubMed |
| 28382315 | Supervised classification of etoposide-treated in vitro adherent cells based on noninvasive imaging morphology. | J Med Imaging (Bellingham) | 2017 | https://conductscience.org/library/papers/28382315 | PubMed |
| 27733284 | Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015. | Lancet | 2016 | https://conductscience.org/library/papers/27733284 | PubMed |
| 26911428 | The Effects of Chemotherapeutic Agents, Bleomycin, Etoposide, and Cisplatin, on Chromatin Remodeling in Male Rat Germ Cells. | Biol Reprod | 2016 | https://conductscience.org/library/papers/26911428 | PubMed |
| 24829158 | The ganglioside GM3 is associated with cisplatin-induced apoptosis in human colon cancer cells. | PLoS One | 2014 | https://conductscience.org/library/papers/24829158 | PubMed |
| 23955676 | Iatrogenic genetic damage of spermatozoa. | Adv Exp Med Biol | 2014 | https://conductscience.org/library/papers/23955676 | PubMed |
| 22402960 | Exposure to bleomycin, etoposide, and cis-platinum alters rat sperm chromatin integrity and sperm head protein profile. | Biol Reprod | 2012 | https://conductscience.org/library/papers/22402960 | PubMed |
| 22242071 | Chemotherapy induced Hyponatraemia. | BMJ Case Rep | 2010 | https://conductscience.org/library/papers/22242071 | PubMed |
| 19680688 | Posttreatment surveillance after paraaortic radiotherapy for stage I seminoma: a systematic analysis. | J Cancer Res Clin Oncol | 2010 | https://conductscience.org/library/papers/19680688 | PubMed |
| 19089452 | Identification of genomic regions contributing to etoposide-induced cytotoxicity. | Hum Genet | 2009 | https://conductscience.org/library/papers/19089452 | PubMed |
| 18987330 | Impact of the chemotherapy cocktail used to treat testicular cancer on the gene expression profile of germ cells from male Brown-Norway rats. | Biol Reprod | 2009 | https://conductscience.org/library/papers/18987330 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/16620142
GET https://conductscience.org/api/papers/v1/16620142/references?page=2